Quick-Muscle Skeletal – SeV Complete Kit used in Molecular Therapy paper

BALTIMORE, January 29, 2019 – Elixirgen Scientific’s Quick-Muscle™ Skeletal – SeV Complete Kit (QMS-SeV) was used in a paper that was recently published in Molecular Therapy. Dr. Guangbin Xia (University of New Mexico)’s publication, “Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9” presents his results using CRISPR/Cas9 genome editing and induced pluripotent stem […]

NOG Mouse

Elixirgen Scientific and CIEA (Central Institute for Experimental Animals) to pursue joint research program to develop humanized NOG mice with Quick-Tissue technology

Elixirgen Scientific reached an agreement with CIEA (Central Institute for Experimental Animals), an industry-leading experimental animal model developer, to conduct joint research for developing humanized NOG mice with Quick-Tissue™ technology.